COVID-19 RAPID ANTIBODY TESTS
Our COVID-19 Rapid Antibody Tests look for the presence of IgM, IgG, and IgA.
-
IgM antibodies are those created by the human body as part of the body's immediate defense against the SARS-CoV-2 virus.
-
IgG antibodies are those created to provide long-term protection against the resurgence of SARS-CoV-2 in the body.
-
IgA is an antibody that plays a crucial role in the immune function of mucous membranes. The amount of IgA produced in association with mucosal membranes is greater than all other types of antibodies combined.
See a demonstration of how the tests work HERE.
We also have surgical masks, N95 NIOSH-approved masks, EPA-approved anti-microbial hard-surface disinfectant, and BZK foaming hand sanitizer.
Our tests are quick, easy, affordable, and accurate:
-
Requires only 2 drops of blood from a finger stick
-
Results in 15 minutes or less
-
No special facilities or lab equipment required
-
No refrigeration required (storage is recommended at 15o to 30o C
-
Each kit comes with 25 individually-wrapped tests, disposable pipettes, diluent solution, and an instruction sheet
-
Not included: alcohol swabs and lancets (this is deemed by the FDA because the tests are NOT meant for home use
-
An internal control line (C=control) area is built-in to assure that the test has been carried out correctly
SASTM COVID-19 Two Line Rapid Total Antibody Detection Test
![GettyImages-929234052 [Converted].png](https://static.wixstatic.com/media/31a2f1_5584812cf82547c987694757895cf164~mv2.png/v1/fill/w_33,h_33,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/GettyImages-929234052%20%5BConverted%5D.png){kind=small}
This rapid visual assay is for the presumptive qualitative detection of IgG and IgM antibodies.
High Sensitivity & Specificity: 99.4%
No false positives reported to date
Cross-reactivity testing = Zero
FDA PEUA201388, issued on 5/22/2020
Available for sale and use now
Validation done by the National Cancer Institute for the full EUA.
Manufactured in accordance with Good Manufacturing Practices (GMP)
Read the SAS IgM/IgG COVID-19 Antibody Detection Test Clinical Performance Report HERE.
Pinnacle BioLabs COVID-19 Novel Coronavirus Dual IgG/IgM Rapid Test
![GettyImages-929234052 [Converted].png](https://static.wixstatic.com/media/31a2f1_5584812cf82547c987694757895cf164~mv2.png/v1/fill/w_34,h_34,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/GettyImages-929234052%20%5BConverted%5D.png){kind=small}
This rapid visual assay is for the presumptive qualitative detection of IgG and IgM antibodies.
Sensitivity: 92%
Specificity: 99%
FDA PEUA200240, issued on 3/28/2020
Available for sale and use now
Clinical trials for sensitivity, specificity, and cross-reactivity completed and validated by independent third parties, such as:
-
The State of Delaware: Read the Study HERE
-
Emory University
-
George Mason University
Read the Pinnacle BioLabs COVID-19 Coronavirus Dual IgG/IgM Rapid Test Product Specifications Master Sheet HERE.
Read follow-up from the Delaware Department of Health and Social Services' Chief Physician HERE.
SASTM COVID-19 One Line Rapid Total Antibody Detection Test
This rapid visual assay is for the presumptive qualitative detection of total antibodies (including IgG, IgM, and IgA) against SARS-CoV-2 from human whole blood, serum, or plasma.
Specificity: 99.4%
No false positives reported to date
Cross-reactivity testing = Zero
FDA PEUA201175, issued on 5/21/2020
Available for sale and use now
Manufactured in accordance with Good Manufacturing Practices (GMP)
![GettyImages-929234052 [Converted].png](https://static.wixstatic.com/media/31a2f1_5584812cf82547c987694757895cf164~mv2.png/v1/fill/w_190,h_190,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/GettyImages-929234052%20%5BConverted%5D.png)